NUWE
Medical Devices · Healthcare
CFO
2021-06-28–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Nuwellis, Inc. publishes a filing, an earnings call transcript or a press release.
Get NUWE alertsGeorge Montague is recorded as CFO at Nuwellis, Inc. (NUWE) since June 28, 2021. Nuwellis, Inc. reported in an 8-K filed September 23, 2022 that George Montague resigned as Chief Financial Officer, effective September 19, 2022. The same filing states: “Mr. Montague’s resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or procedures.” Nuwellis, Inc. reported in an 8-K filed June 22, 2021 that George Montague was appointed Chief Financial Officer and Treasurer, effective June 28, 2021. The proxy statement of Nuwellis, Inc. reports total compensation of $282,583 for George Montague in fiscal 2022, including a base salary of $273,370. Disclosed compensation is on record for 2 fiscal years. George Montague has spoken on 5 earnings calls across 1 company, most recently for Nuwellis, Inc. on August 9, 2022. Nuwellis, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Nuwellis, Inc. includes John L. Erb (CEO, Chairman, CFO and Board Member), Michael McCormick (CEO), Nestor Jaramillo (CEO) and 7 others.
“On September 19, 2022, George Montague notified Nuwellis, Inc., a Delaware corporation (the "Company") of his decision to resign as the Chief Financial Officer of the Company.”
“Mr. Montague’s resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or procedures.”
“Effective June 28, 2021, George Montague was appointed as Chief Financial Officer and Treasurer of Nuwellis, Inc. (the “Company”).”
“Revenue for the second quarter was $2.2 million, representing 15% sequential growth from the first quarter of 2022 and down 12% compared to the prior year period.”
“Turning to our financial results, revenue for the first quarter was $1.93 million representing 17% sequential growth from the fourth quarter of 2021, and essentially even with the prior year period.”
“Revenue for the fourth quarter was $1.6 million, down 20% from the fourth quarter of last year and 11% below the third quarter of 2021. Most of the sequential decline versus the prior quarter is attributable to lower U.S. console sales, a seasonal pattern that we have seen in three of the past four years.”
“Turning to our financial results, revenue for the third quarter was $1.9 million down 2.7% from the third quarter of last year and 26.1% below the second quarter of 2021.”
“I'm glad to be part of Nuwellis and look forward to helping the business achieve its potential as it transforms the lives of patients suffering from fluid overload through science, collaboration, and innovation.”
2021-06-28–present
2021-06-28–2022-09-19
Start not stated–2022-09-19
NUWE
Medical Devices · Healthcare
CFO
2021-06-28–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Nuwellis, Inc. (NUWE) | Former Chief Financial Officer | $273,370 | $282,583 |
| 2021 | Nuwellis, Inc. (NUWE) | Former Chief Financial Officer | $166,250 | $453,044 |
“Mr. Montague’s resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or procedures.”
Nuwellis, Inc. (NUWE)